Pendekatan Terapi Polycystic Ovary Syndrome (PCOS)

Abstract

Polycystic Ovary Syndrome (PCOS) juga dikenal sebagai hyperandrogenic anovulation (HA), merupakan kelainan sistem endokrin yang menyebabkan gangguan kesuburan wanita usia reproduktif. PCOS melibatkan ketidakseimbangan kadar luteinizing hormone (LH) dan follicle-stimulating hormone (FSH), resistensi insulin, dan kelainan metabolisme. Clomiphene citrate masih menjadi pilihan terapi utama untuk menstimulasi ovulasi pada kasus PCOS. Metformin juga menurunkan kadar androgen yang dapat meningkatkan terjadinya ovulasi spontan. Terapi lini kedua adalah gonadotropin dan bedah laparoskopi ovarium. Polycystic Ovarian Syndrome (PCOS), also referred to as hyperandrogenic anovulation (HA), is an endocrine system disorders that affect women in their reproductive age. PCOS typically involves hormonal imbalances between luteinizing hormone (LH) and follicle-stimulating hormone (FSH), insulin resistance, and metabolic abnormalities. Clomiphene citrate (CC) is considered the first line treatment for ovulation induction in women with Polycystic Ovary Syndrome (PCOS). Metformin also decreases androgens in both lean and obese women, leading to increased rates of spontaneous ovulation. Second choice is gonadotropin and ovarianlaparoscopy.